Proteins of purified Epstein-Barr virus
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mature Epstein-Barr virus (EBV) was purified from the culture medium of infected lymphocytes made functionally conditional for Zta activation of lytic replication by an in-frame fusion with a mutant estrogen receptor. Proteins in purified virus preparations were separated by gradient gel electrophoresis and trypsin-digested; peptides were then analyzed by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans. Potential peptides were matched with EBV and human gene ORFs. Mature EBV was mostly composed of homologues of proteins previously found in a herpes virion. However, EBV homologues to herpes simplex virus capsid-associated or tegument components UL7 (BBRF2), UL14 (BGLF3), and EBV BFRF1 were not significantly detected. Instead, probable tegument components included the EBV and γ-herpesvirus-encoded BLRF2, BRRF2, BDLF2 and BKRF4 proteins. Actin was also a major tegument protein, and cofilin, tubulin, heat shock protein 90, and heat shock protein 70 were substantial components. EBV envelope glycoprotein gp350 was highly abundant, followed by glycoprotein gH, intact and furin-cleaved gB, gM, gp42, gL, gp78, gp150, and gN. BILF1 (gp64) and proteins associated with latent EBV infection were not detected in virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For compositional analysis, most studies have focused on viruses with high proteomic complexity, including those in the families Herpesviridae (4–9) and Poxviridae (10–12).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [4]
Citations
Cites
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography
Grünewald, K., Desai, P., Winkler, D. C., Heymann, J. B., Belnap, D. M., Baumeister, W., & Steven, A. C. (2003) · Science · doi:10.1126/science.1090284 · Cited by 586
Evolution of the herpesviruses
Davison, A. J. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00492-8 · Cited by 336
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
The UL6 Gene Product Forms the Portal for Entry of DNA into the Herpes Simplex Virus Capsid
Newcomb, W. W., Juhas, R. M., Thomsen, D. R., Homa, F. L., Burch, A. D., Weller, S. K., & Brown, J. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10923-10932.2001 · Cited by 309
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Proteins associated with purified human cytomegalovirus particles
Baldick, C. J., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6097-6105.1996 · Cited by 176
Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H., & Saifuddin, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4376 · Cited by 169
Grogan, E. A., Jenson, H. B., Countryman, J. K., Heston, L., Gradoville, L., & Miller, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1332 · Cited by 137
Research works printed but not linked: 2
- Hutt-Fletcher, L. M. & Lake, C. M. (2001) Curr. Top. Microbiol. Immunol. 258, 51-64.11443867
- Iwase, H. & Hotta, K. (1993) Methods Mol. Biol. 14, 151-159.8348231
Cited by
Epstein–Barr virus and virus human protein interaction maps
Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702332104 · Cited by 388
Self-citationHerpesvirus assembly: An update
Mettenleiter, T. C., Klupp, B. G., & Granzow, H. (2009) · Virus Research · doi:10.1016/j.virusres.2009.03.018 · Cited by 375
Comprehensive Characterization of Extracellular Herpes Simplex Virus Type 1 Virions
Loret, S., Guay, G., & Lippé, R. (2008) · Journal of Virology · doi:10.1128/jvi.00904-08 · Cited by 365
Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell
Radtke, K., Dohner, K., & Sodeik, B. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00679.x · Cited by 346
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
“One of the most abundant of these in the virus envelope, gp350/220 (22), is responsible for attachment of the virus with high affinity (36) to the complement receptor type 2 (CR2) on B cells (7, 8, 40, 41, 60, 61).”
Background
Metadata
- Authors
- Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kieff, Elliott
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-08
- Volume
- 101
- Issue
- 46
- Pages
- 16286-16291
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC528973
- OpenAlex
- W2080385928
- Cited by
- 450
- References
- 35
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 31 · 2023: 31 · 2022: 21 · 2021: 15 · 2020: 23 · 2019: 19 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 19 · 2013: 13 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- National Institutes of Health (5k08ai049943-02)
- National Cancer Institute (CA47006, CA 85180, R35CA047006, P01CA087661, R01CA047006, R01CA085180, CA87661)
- National Institute of Allergy and Infectious Diseases (1K-08 AI49943-03)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- Epstein-Barr virus, tegument proteins, envelope glycoprotein, lytic replication, actin, cofilin, heat shock proteins, latent infection
- MeSH terms
- Chromatography, Liquid, Clone Cells, Herpesvirus 4, Human, Humans, Lymphocytes, Microscopy, Electron, Phosphorylation, Mass Spectrometry, Viral Envelope Proteins, Viral Proteins, Virus Replication, Open Reading Frames, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proteins of purified Epstein-Barr virus. https://app.cochat.ai/papers/10.1073/pnas.0407320101
- The paper
- Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E. (2004). Proteins of purified Epstein-Barr virus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0407320101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.